Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSIF.L Regulatory News (SSIF)

  • There is currently no data for SSIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

25 Sep 2015 16:49

RNS Number : 2932A
GLI Alternative Finance PLC
25 September 2015
 



 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

GLI Alternative Finance Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Morgan Stanley

(Institutional Securities Group and Global Wealth Management)

4. Full name of shareholder(s)  (if different from 3.):iv

Morgan Stanley & Co. International plc

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

23/09/2015

6. Date on which issuer notified:

25/09/2015

7. Threshold(s) that is/are crossed orreached: vi, vii

3%,4%,5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00BYMK5S87

 

Below 3%

 

 

Below 3%

 

3,000,000

3,000,000

 

 

5.69%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,000,000

5.69%

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA is a direct holder of  3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley Investments (UK)

 

Morgan Stanley Investments (UK), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley UK Group

 

Morgan Stanley UK Group, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley Group (Europe)

 

Morgan Stanley Group (Europe), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley International Limited

 

Morgan Stanley International Limited, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley International Holdings Inc.

 

Morgan Stanley International Holdings Inc, c/o The Corporation Trust Company, Corporation Trust Centre, 1209 Orange Street, Wilmington, Delaware DE19801, USA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley.

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

 

 

14. Contact name:

Craig Horsley

15. Contact telephone number:

0141 245 7736

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVSVRVNAKUAR
Date   Source Headline
16th Sep 20203:00 pmRNSDirector Declaration
15th Sep 20202:00 pmRNSDirector Declaration
26th Aug 20204:00 pmRNSMonthly Net Asset Value, Dividend and Fact Sheet
20th Aug 20207:00 amRNSPublication of Circular and notice of GM
30th Jul 20207:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
23rd Jul 20207:00 amRNSChange of Name
14th Jul 202010:15 amRNSCompany Update – Conclusion of Strategic Review
9th Jul 20207:00 amRNSAppointment of Director
25th Jun 20207:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
19th Jun 202012:30 pmRNSResult of General Meeting
8th Jun 202012:20 pmRNSAppointment of Investment Manager
28th May 202010:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
26th May 20207:00 amRNSBoard Changes
26th May 20207:00 amRNSContinuation Vote and Notice of General Meeting
30th Apr 20204:25 pmRNSMonthly Net Asset Value, Dividend and Fact Sheet
30th Apr 202011:40 amRNSUpdate on Continuation Vote and Mgmt Arrangements
27th Apr 20207:00 amRNSContinuation Vote
31st Mar 20207:00 amRNSHalf-Yearly Financial Report
25th Mar 20207:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
27th Feb 20207:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
30th Jan 20207:00 amRNSMonthly net asset value, dividend and fact sheet
23rd Jan 20206:30 pmRNSFund update
14th Jan 20203:00 pmRNSHolding(s) in Company
31st Dec 20197:00 amRNSMonthly Net Asset Value and Fact Sheet
18th Dec 20197:00 amRNSDividend Declaration
17th Dec 20192:39 pmRNSResult of AGM
27th Nov 20197:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
31st Oct 20197:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
16th Oct 20197:00 amRNSMonthly Net Asset Values and Fact Sheets
16th Oct 20197:00 amRNSAnnual Financial Report
8th Oct 20198:00 amRNSInvestment Update - October 2019
25th Sep 20197:00 amRNSDividend Declaration
29th Aug 20197:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
25th Jul 20192:21 pmRNSMonthly Net Asset Value, Dividend and Fact Sheet
22nd Jul 201912:07 pmRNSHolding(s) in Company
4th Jul 20191:00 pmRNSDirector Declaration
25th Jun 20197:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
29th May 20197:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
13th May 201910:30 amRNSDirector/PDMR Shareholding
24th Apr 20197:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
27th Mar 20197:00 amRNSMonthly net asset value, dividend and fact sheet
14th Mar 20197:00 amRNSHalf-year Report
8th Mar 20195:00 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
15th Feb 20199:00 amRNSKepler Trust Intelligence: New Research
14th Feb 201911:00 amRNSHolding(s) in Company
30th Jan 20197:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
21st Dec 20187:01 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
19th Dec 20187:00 amRNSDirectors' roles and responsibilities
18th Dec 20184:02 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.